The kinetic and molecular docking analysis of interactions between three V-type nerve agents and four human cholinesterases

被引:1
|
作者
Li, Kexin [1 ,2 ]
Liu, Yulong [1 ,2 ]
Liu, Yanqin [1 ,2 ]
Li, Qian [3 ,4 ]
Guo, Lei [1 ,2 ]
Xie, Jianwei [1 ,2 ]
机构
[1] Acad Mil Med Sci, State Key Lab Toxicol & Med Countermeasures, 27 Taiping Rd, Beijing 100850, Peoples R China
[2] Acad Mil Med Sci, Inst Pharmacol & Toxicol, Lab Toxicant Anal, 27 Taiping Rd, Beijing 100850, Peoples R China
[3] State Key Lab Toxicol & Med Countermeasures, 27 Taiping Rd, Beijing 100850, Peoples R China
[4] Beijing Inst Pharmacol & Toxicol, 27 Taiping Rd, Beijing 100850, Peoples R China
关键词
V -type nerve agents; Acetylcholinesterase; Butyrylcholinesterase; Native; Recombinant; Enzyme kinetics; Molecular docking; HUMAN BUTYRYLCHOLINESTERASE; HUMAN ACETYLCHOLINESTERASE; ORGANOPHOSPHORUS COMPOUNDS; REACTIVATION; INHIBITION; DYNAMICS; OXIMES; SARIN;
D O I
10.1016/j.cbi.2023.110369
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G and V-type nerve agents represent the most toxic chemical warfare agents. Their primary toxicity was the consequence of the covalent inhibition of the pivotal acetylcholinesterase (AChE), which induces overstimulation of cholinergic receptors and overaccumulation of cholines, eventually leading to death by respiratory arrest. The inhibitory and reactivation kinetics of cholinesterase (ChE) are essential for the toxicology and countermeasures of nerve agents. Medical defensive research on V-type nerve agents (V agents) has been mainly reported on VX and VR. Here we demonstrated the first systematical kinetic analysis between the type of ChE [native or re-combinant human AChE and butyrylcholinesterase (BChE)] and three V agents, including VX, VR, and Vs, another isomer of VX, and highlighted the effects of native and recombinant ChE differences. The spontaneous reactivation and aging kinetics data of Vs-inhibited BChEs were firstly reported here.The results showed that AChE was more easily inhibited by three V agent compared to BChE, regardless of whether it is native or recombinant. The increased inhibitory potency order on AChE was VX, Vs, then VR, and on BChE was VX, then Vs and VR. The difference between native and recombinant ChE could influence the inhibition, aging, and spontaneous reactivation kinetics of three V agents, whether AChE or BChE, which was systematically revealed for the first time. For inhibition kinetics, the ki of three V agents for recombinant AChE was significantly higher than native AChE, and the stronger the inhibitory potency of V agents, the more pro-nounced difference in ki. In terms of aging and spontaneous reactivation kinetics, recombinant ChE was found to be more prone to spontaneous reactivation, but more resistant to aging compared to native ChE, particularly for AChE. The performed covalent molecular docking results partially explained the effects of differences between native and recombinant ChE on enzyme kinetics from the perspective of binding energy and conformation.
引用
收藏
页数:9
相关论文
共 10 条
  • [1] The reactivation kinetic analysis, molecular docking, and dynamics of oximes against three V-type nerve agents inhibited four human cholinesterases
    Li, Kexin
    Liu, Yulong
    Liu, Yanqin
    Li, Qian
    Guo, Lei
    Xie, Jianwei
    CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 396
  • [2] Molecular dynamics simulations of organophosphorus acid anhydrase interactions with V-type organophosphate nerve agents
    Phillips, Joshua L.
    Harvey, Steven P.
    Gnanakaran, Sandrasegaram
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [3] Inhibition of Human Acetylcholinesterase by Enantiomers of V-Type Chemical Warfare Nerve Agents and Analogs
    Boeri, Michael
    Kasten, Shane
    Cerasoli, Douglas
    FASEB JOURNAL, 2015, 29
  • [4] Tracing and attribution of V-type nerve agents in human exposure by strategy of assessing the phosphonylated and disulfide adducts on ceruloplasmin
    Fu, Feiyan
    Chen, Jialin
    Zhao, Pengcheng
    Lu, Xiaogang
    Gao, Runli
    Chen, Dong
    Liu, Haibo
    Wang, Hongmei
    Pei, Chengxin
    TOXICOLOGY, 2020, 430
  • [5] Cysteine-proline disulfide adducts from human serum albumin as potential novel biomarkers for verification of exposure to V-type nerve agents
    Kranawetvogl, A.
    Thiermann, H.
    Tsoutsoulopoulos, A.
    John, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S56 - S56
  • [6] Investigation of the interactions between three flavonoids and human serum albumin by isothermal titration calorimetry, spectroscopy, and molecular docking
    Zhang, Ning
    He, Hangyu
    Zhang, Miao
    Lv, Xinluan
    Li, Wenjin
    Wang, Ruiyong
    Chang, Junbiao
    NEW JOURNAL OF CHEMISTRY, 2022, 46 (26) : 12814 - 12824
  • [7] In Silico Analysis of Binding Interactions between GSK983 and Human DHODH through Docking and Molecular Dynamics
    Bernaldez, M. J. A.
    Billones, J. B.
    Magpantay, A.
    4TH ELECTRONIC AND GREEN MATERIALS INTERNATIONAL CONFERENCE 2018 (EGM 2018), 2018, 2045
  • [8] Biophysical characterization of interactions between falcarinol-type polyacetylenes and human serum albumin via multispectroscopy and molecular docking techniques
    Wang, Yi
    Liu, Jia
    Zhu, Meiqing
    Wang, Lijun
    Zen, Xianyang
    Fan, Shisuo
    Wang, Zhen
    Li, Honglian
    Na, Risong
    Zhao, Xi
    Li, Qing X.
    JOURNAL OF LUMINESCENCE, 2018, 200 : 111 - 119
  • [9] Comparison of non-covalent binding interactions between three whey proteins and chlorogenic acid: Spectroscopic analysis and molecular docking
    Zhang, Yuanyuan
    Lu, Yingcong
    Yang, Yang
    Li, Siyao
    Wang, Ce
    Wang, Cuina
    Zhang, Tiehua
    FOOD BIOSCIENCE, 2021, 41
  • [10] Molecular Docking Analysis of Selected Urtica dioica Constituents As Human Carbonic Anhydrase II (hCA-II), Human 11 Beta-Hydroxysteroid Dehydrogenases Type 1 (h11beta-HSD1), and Human Dual Specificity Phosphatase (hCDC25B) Inhibitory Agents
    Arulselvan, Angel Jenifer
    Manimuthu, Mani Sankar
    Narayanaswamy, Radhakrishnan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)